Downloads
SB 534 — Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients
by Senator Harrell
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Health Policy Committee (HP)
The bill amends s. 409.912, F.S., to create an exception from step-therapy prior authorization requirements within the Florida Medicaid program for a drug product if the prescribing physician provides the Agency for Health Care Administration with written medical or clinical documentation that the product is medically necessary. Under the bill, medical necessity is created when the drug product or a medication of a similar drug class is being prescribed for the treatment of schizophrenia or schizotypal or delusional disorders, prior authorization has previously been granted to the patient for the prescribed drug, and the medication was dispensed to the patient during the previous 12 months.
If approved by the Governor, these provisions take effect July 1, 2022.
Vote: Senate 38-0; House 112-0